ACSS2 inhibitor MTB-9655
Term · Oncology and biomedicine · MLC-T-ONC-009612
An orally bioavailable small molecule inhibitor of the enzyme human acetyl coenzyme A synthetase short chain family member 2 (ACSS2; acetyl CoA synthetase 2), with potential antineoplastic activity. Upon oral administration, the ACSS2 inhibitor MTB-9655 selectively targets, binds to and inhibits the activity of ACSS2. This prevents acetate metabolism to acetyl-CoA which may lead to an inhibition of tumor cell proliferation. ACSS2, an enzyme that converts acetate to acetyl-CoA, is upregulated in cancer cells in response to low nutrient availability and hypoxia. Stressed cancer cells utilize acetate as an alternative nutrient source for cell growth.
| Identifier | MLC-T-ONC-009612 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | acetyl-CoA synthetase 2 inhibitor MTB-9655 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009612",
"term": "ACSS2 inhibitor MTB-9655",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small molecule inhibitor of the enzyme human acetyl coenzyme A synthetase short chain family member 2 (ACSS2; acetyl CoA synthetase 2), with potential antineoplastic activity. Upon oral administration, the ACSS2 inhibitor MTB-9655 selectively targets, binds to and inhibits the activity of ACSS2. This prevents acetate metabolism to acetyl-CoA which may lead to an inhibition of tumor cell proliferation. ACSS2, an enzyme that converts acetate to acetyl-CoA, is upregulated in cancer cells in response to low nutrient availability and hypoxia. Stressed cancer cells utilize acetate as an alternative nutrient source for cell growth.",
"synonyms": [
"acetyl-CoA synthetase 2 inhibitor MTB-9655"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/acss2-inhibitor-mtb-9655/"
}
Record 280 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.